Diclofenac Potassium | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Diclofenac Potassium
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Diclofenac Potassium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 11 USDMF, 6 CEP/COS, 4 EU WC, 1 KDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

31 API Suppliers
11 USDMF
6 CEP/COS
4 EU WC
1 KDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

141 FDF Dossiers, 27 FDA Orange Book, 48 Europe, 5 Canada, 8 South Africa, 53 Listed Dossiers

141 FDF Dossiers
27 FDA Orange Book
48 Europe
5 Canada
8 South Africa
53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Rochem International Inc, 18 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 25 BASF, 1 Bioplus Life Sciences, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 39 Direct Compression, 34 Disintegrants & Superdisintegrants, 33 Granulation, 31 Thickeners and Stabilizers, 30 Taste Masking, 26 Solubilizers, 24 Parenteral, 22 Controlled & Modified Release, 20 Chewable & Orodispersible Aids, 20 Film Formers & Plasticizers, 17 Topical, 15 Lubricants & Glidants, 15 Co-Processed Excipients, 9 Empty Capsules, 8 Emulsifying Agents, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

77 Fillers, Diluents & Binders
46 Coating Systems & Additives
39 Direct Compression
34 Disintegrants & Superdisintegrants
33 Granulation
31 Thickeners and Stabilizers
30 Taste Masking
26 Solubilizers
24 Parenteral
22 Controlled & Modified Release
20 Chewable & Orodispersible Aids
20 Film Formers & Plasticizers
17 Topical
15 Lubricants & Glidants
15 Co-Processed Excipients
9 Empty Capsules
8 Emulsifying Agents
7 Rheology Modifiers
6 Surfactant & Foaming Agents
6 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 1 Regulatory FDF Prices

18 US Medicaid Prescriptions
1 Regulatory FDF Prices

MARKET PLACE

22 APIs, 5 FDF Dossiers

22 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 2 Health Canada Patents

10 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

1 EDQM
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 17 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

10 All

01 10ASIO HOLDINGS

filter Patent Number Reset all filters

10 All

01 17662858

02 17759394

03 17884095

04 17939518

05 18097651

06 18110606

07 18623920

08 18927604

09 19561200

10 19827197

filter API Patent Reset all filters

10 All

01 2Y

02 8Blank

filter FDF Patent Reset all filters

10 All

01 3Y

02 7Blank

filter Expiration Date Reset all filters

10 All

01 42026-06-16

02 62029-02-24

Product Main Page

01

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-02-24

DICLOFENAC POTASSIUM

US Patent Number : 7884095

Drug Substance Claim :

Drug Product Claim :

Application Number : 22202

Patent Use Code : U-1111

Delist Requested :

Patent Use Description : NONSTEROIDAL ANTI-INFL...

Patent Expiration Date : 2029-02-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-02-24

DICLOFENAC POTASSIUM

US Patent Number : 8110606

Drug Substance Claim :

Drug Product Claim :

Application Number : 22202

Patent Use Code : U-980

Delist Requested :

Patent Use Description : NONSTEROIDAL ANTI-INFL...

Patent Expiration Date : 2029-02-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-16

DICLOFENAC POTASSIUM

US Patent Number : 8097651

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22165

Patent Use Code : U-436

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2026-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-02-24

DICLOFENAC POTASSIUM

US Patent Number : 7662858

Drug Substance Claim :

Drug Product Claim :

Application Number : 22202

Patent Use Code : U-1035

Delist Requested :

Patent Use Description : NONSTEROIDAL ANTI-INFL...

Patent Expiration Date : 2029-02-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-02-24

DICLOFENAC POTASSIUM

US Patent Number : 7939518

Drug Substance Claim :

Drug Product Claim :

Application Number : 22202

Patent Use Code : U-980

Delist Requested :

Patent Use Description : NONSTEROIDAL ANTI-INFL...

Patent Expiration Date : 2029-02-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-02-24

DICLOFENAC POTASSIUM

US Patent Number : 8623920

Drug Substance Claim :

Drug Product Claim :

Application Number : 22202

Patent Use Code : U-1482

Delist Requested :

Patent Use Description : DICLOFENAC POTASSIUM F...

Patent Expiration Date : 2029-02-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-02-24

DICLOFENAC POTASSIUM

US Patent Number : 9561200

Drug Substance Claim :

Drug Product Claim :

Application Number : 22202

Patent Use Code : U-1482

Delist Requested :

Patent Use Description : DICLOFENAC POTASSIUM F...

Patent Expiration Date : 2029-02-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-16

DICLOFENAC POTASSIUM

US Patent Number : 7759394

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22165

Patent Use Code : U-436

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2026-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-16

DICLOFENAC POTASSIUM

US Patent Number : 8927604

Drug Substance Claim :

Drug Product Claim :

Application Number : 22165

Patent Use Code : U-436

Delist Requested :

Patent Use Description : ACUTE TREATMENT OF MIG...

Patent Expiration Date : 2026-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

ASIO HOLDINGS

DICLOFENAC POTASSIUM

OTS 2025

Not Confirmed

ASIO HOLDINGS

Country

OTS 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-16

DICLOFENAC POTASSIUM

US Patent Number : 9827197

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22165

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!